A detailed history of Kmg Fiduciary Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kmg Fiduciary Partners, LLC holds 7,429 shares of AMGN stock, worth $2.38 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,429
Previous 7,454 0.34%
Holding current value
$2.38 Million
Previous $2.12 Million 9.53%
% of portfolio
0.23%
Previous 0.22%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $6,568 - $7,982
-25 Reduced 0.34%
7,429 $2.32 Million
Q1 2024

Apr 10, 2024

SELL
$268.87 - $324.56 $2.17 Million - $2.62 Million
-8,078 Reduced 52.01%
7,454 $2.12 Million
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $75,942 - $85,672
297 Added 1.95%
15,532 $4.47 Million
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $121,788 - $151,203
557 Added 3.79%
15,235 $4.09 Million
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $1.79 Million - $2.12 Million
8,362 Added 132.39%
14,678 $3.26 Million
Q1 2023

Apr 13, 2023

SELL
$225.79 - $275.2 $116,733 - $142,278
-517 Reduced 7.57%
6,316 $1.53 Million
Q4 2022

Jan 12, 2023

SELL
$229.03 - $291.01 $367,364 - $466,780
-1,604 Reduced 19.01%
6,833 $0
Q3 2022

Oct 27, 2022

SELL
$224.46 - $253.15 $1.1 Million - $1.24 Million
-4,882 Reduced 36.65%
8,437 $1.9 Million
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $678,056 - $754,558
-2,939 Reduced 18.08%
13,319 $3.24 Million
Q1 2022

Apr 19, 2022

SELL
$219.27 - $242.57 $762,840 - $843,901
-3,479 Reduced 17.63%
16,258 $3.93 Million
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $141,204 - $161,596
710 Added 3.73%
19,737 $4.44 Million
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $546,595 - $640,402
2,575 Added 15.65%
19,027 $4.05 Million
Q2 2021

Jul 20, 2021

BUY
$233.58 - $259.14 $89,928 - $99,768
385 Added 2.4%
16,452 $4.01 Million
Q1 2021

Apr 08, 2021

BUY
$221.91 - $258.6 $263,407 - $306,958
1,187 Added 7.98%
16,067 $4 Million
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $247,105 - $294,259
1,142 Added 8.31%
14,880 $3.39 Million
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $29,800 - $33,140
127 Added 0.93%
13,738 $3.49 Million
Q2 2020

Jul 22, 2020

BUY
$197.81 - $242.74 $653,762 - $802,255
3,305 Added 32.07%
13,611 $3.21 Million
Q1 2020

Apr 29, 2020

BUY
$182.24 - $241.7 $259,327 - $343,939
1,423 Added 16.02%
10,306 $2.09 Million
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $669,992 - $861,171
3,541 Added 66.29%
8,883 $2.14 Million
Q3 2019

Oct 15, 2019

SELL
$174.11 - $208.62 $111,430 - $133,516
-640 Reduced 10.7%
5,342 $1.03 Million
Q2 2019

Jul 26, 2019

BUY
$166.7 - $195.41 $71,681 - $84,026
430 Added 7.74%
5,982 $1.1 Million
Q1 2019

Apr 16, 2019

BUY
$180.87 - $203.88 $16,278 - $18,349
90 Added 1.65%
5,552 $1.06 Million
Q4 2018

Apr 15, 2019

BUY
$178.4 - $208.25 $974,420 - $1.14 Million
5,462 New
5,462 $1.06 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kmg Fiduciary Partners, LLC Portfolio

Follow Kmg Fiduciary Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.